SBSB
EXAS

Sullivan, Bruyette, Speros & Blaney’s Exact Sciences EXAS Stock Holding History

Sullivan, Bruyette, Speros & Blaney’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$173K Sell
1,313
-1,043
-44% -$143K 0.01% 332
2020
Q4 		$312K Sell
2,356
-494
-17% -$59.7K 0.01% 223
2020
Q3 		$291K Buy
2,850
+250
+10% +$21.6K 0.02% 206
2020
Q2 		$226K Buy
+2,600
New +$208K 0.01% 216

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Sullivan, Bruyette, Speros & Blaney's EXAS Position: Q1 2021 in Review

Sullivan, Bruyette, Speros & Blaney reduced its Exact Sciences (EXAS) stake by 44% in Q1 2021, selling an estimated $143K and leaving 1,313 shares worth $173K. The position accounts for 0.01% of the portfolio, ranked #332.

Sullivan, Bruyette, Speros & Blaney first reported a position in EXAS in Q2 2020 and has held it in 4 quarters since. The position peaked at $312K in Q4 2020. 645 funds tracked by Wall St. Rank hold EXAS as of Q1 2021.

  • Sullivan, Bruyette, Speros & Blaney held 1,313 shares of Exact Sciences worth $173K as of Q1 2021.
  • Sullivan, Bruyette, Speros & Blaney sold 1,043 Exact Sciences shares in Q1 2021, an estimated $143K.
  • Exact Sciences made up 0.01% of Sullivan, Bruyette, Speros & Blaney's portfolio in Q1 2021, its #332 holding.
  • Sullivan, Bruyette, Speros & Blaney first reported a position in Exact Sciences in Q2 2020 and has held it in 4 quarters since.
  • Sullivan, Bruyette, Speros & Blaney's Exact Sciences position peaked at $312K in Q4 2020.
  • 645 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2021.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.